Abstract: A terminal (60) in a digital broadcasting system supports a virtual machine (150), such as a Java™ virtual machine, which processes applications in a first code format, such as Java™ byte code. A plug-in (110) is provided which converts applications that are received in a second code format into the first code format. The plug-in (110) can compile (120) the application into the first code format. The application can be compiled (120) upon receipt, or it may be stored (69) and compiled at a later time, such as overnight or when the virtual machine (150) has spare processing capacity (114). Applications can be converted based on monitored usage statistics (112).

Abstract: A soluble receptor to IL-20 having two polypeptide subunits, IL-20RA (formerly called ZcytoR7) and IL-20RB (formerly called DIRS1). The two subunits are preferably linked together. In one embodiment one subunit is fused to the constant region of the light chain of an immunoglobulin, and the other subunit is fused to the constant region of the heavy chain of the immunoglobulin. The light chain and the heavy chain are connected via a disulfide bond.

Abstract: Antibodies that bind to polypeptides and peptides comprising the sequence of zalpha11 Ligand as shown in SEQ ID NO: 2 are described. The antibodies may bind the full length sequence of 162 amino acid residues or a fragment thereof, including a mature polypeptide of 131 amino acid residues and smaller polypeptide and peptide sequences. The antibodies may include antibodies that are polyclonal, monoclonal, murine, humanized or neutralizing. Methods for producing the antibodies are also described.

Abstract: Antibodies that bind to polypeptides and peptides comprising the sequence of zalpha11 Ligand as shown in SEQ ID NO: 2 are described. The antibodies may bind the full length sequence of 162 amino acid residues or a fragment thereof, including a mature polypeptide of 131 amino acid residues and smaller polypeptide and peptide sequences. The antibodies may include antibodies that are polyclonal, monoclonal, murine, humanized or neutralizing. Methods for producing the antibodies are also described.

Abstract: Antibodies that bind to polypeptides and peptides comprising the sequence of zalpha11 Ligand as shown in SEQ ID NO: 2 are described. The antibodies may bind the full length sequence of 162 amino acid residues or a fragment thereof, including a mature polypeptide of 131 amino acid residues and smaller polypeptide and peptide sequences. The antibodies may include antibodies that are polyclonal, monoclonal, murine, humanized or neutralizing. Methods for producing the antibodies are also described.

Abstract: The present invention provides isolated DNA molecules comprising a DNA segment encoding novel human Kunitz-type inhibitors. Also provided are DNA constructs comprising a first DNA segment encoding a novel human Kunitz-type inhibitor wherein said first DNA segment is operably linked to additional DNA segments required for the expression for the first DNA segment, as well as host cells containing such DNA constructs and methods for producing proteins from the host cells.

Abstract: A method is provided for efficiently accessing information 418, 510 from an automated menu based system 314 using a wireless communications device 102 and deploying services by utilizing the PTT contact list. Having a formatted PTT contact which connects to a voice portal or directly to the desired content from the handset itself enables carriers as well as users the ability to subscribe to information services with minimal setup, user interaction, and in a personalized manner.

Abstract: Methods for treating cancer by co-administering a therapeutic monoclonal antibody with IL-21 are described. Exemplary monoclonal antibodies that can be used are rituximab, trastuzumab and anti-CTLA-4 antibodies. The enhanced antitumor of the combination therapy is particularly useful for patient populations that are recalcitrant to monoclonal therapy, relapse after treatment with monoclonal antibodies or where the enhanced IL-21 antitumor effect reduces toxicities associated with treatment using the monoclonal antibodies.

Abstract: A high K layer, such as aluminum oxide or hafnium oxide, may be formed with a deposition process that uses an ion implantation to damage portions of the high K material that are to be later etched. More particularly, in one implementation, a semiconductor device is manufactured by forming a first dielectric over a substrate, forming a charge storage element over the first dielectric, forming a second dielectric above the charge storage element, implantation ions into select portions of the second dielectric, and etching the ion implanted select portions of the second dielectric.

Abstract: A lifting device for a toilet seat allowing the user to raise and lower the toilet seat without having to physically touch the seat. The device consists of a mounting plate, a shield, and a lifting member, with all surface being curved and without crevices. The shield extends horizontally and vertically beyond the edges of the lifting member.

Abstract: The present invention relates to zalpha11 Ligand polynucleotide and polypeptide molecules. The zalpha11 Ligand is a novel cytokine. The polypeptides may be used within methods for stimulating the proliferation and/or development of hematopoietic cells in vitro and in vivo. The present invention also includes methods for producing the protein, uses therefor and antibodies thereto.

Abstract: An endoluminal prosthesis comprises a prosthetic trunk having a trunk lumen and a trunk wall, a first prosthetic branch having a first branch lumen and a branch wall, and a second prosthetic branch having a second branch lumen. The first branch lumen and the second branch lumen are both in fluid communication with the trunk lumen through the trunk wall and the second branch lumen is in fluid communication with the first branch lumen through the branch wall. Additional devices, systems, and methods are disclosed.

Abstract: An electrically actuated, hydraulic power steering system is provided. The steering system includes a hydraulic pump for generating hydraulic pressure, a hydraulic fluid reservoir, a hydraulic cylinder, and a control valve arrangement that selectively connects the hydraulic cylinder to the pump and the hydraulic fluid reservoir. The control valve arrangement is characterized during the on-center position by a first and a second chamber of the hydraulic cylinder being in fluid communication with each other but not with the fluid reservoir. In one embodiment, the steering system has a steering sensor, a control box, and two pressure accumulators for providing at least two levels of steering assist.

Abstract: The present invention relates to zalpha11 Ligand polynucleotide and polypeptide molecules. The zalpha11 Ligand is a novel cytokine. The polypeptides may be used within methods for stimulating the proliferation and/or development of hematopoietic cells in vitro and in vivo. The present invention also includes methods for producing the protein, uses therefor and antibodies thereto.

Abstract: A tubular separation system for separating a mixture of hydrocarbons and air at a fuel tank in an automotive vehicle, comprises; a fuel tank containing hydrocarbon fuel and a mixture of hydrocarbon fuel vapor and air; a fuel filler pipe connected to the fuel tank for conveying hydrocarbon fuel from a source of hydrocarbon fuel into the fuel tank; a separation module comprising a membrane for separating the hydrocarbon vapor from air; a first tubular member between the fuel tank and the separation module for conveying the mixture of air and hydrocarbon fuel vapor from the fuel tank to the separation module; a second tubular member between the separation module and the fuel tank for conveying hydrocarbon fuel vapor, separated from the mixture of air and hydrocarbon fuel vapor, from the separation module to the fuel tank; and a third tubular member between the separation module and the fuel filler pipe for conveying air, separated from the mixture of air and hydrocarbon fuel vapor, from the separation module to

Abstract: An evaporative emissions system is used in an automotive evaporative emission system including a fuel tank coupled to an automotive engine to control emission of fuel vapors to the atmosphere. The system includes (1) an evaporative emissions canister comprising a unitary molded housing having a circumferential side member, a top member and a bottom member; a hydrocarbon-adsorbing material disposed therein so as to provide a vapor adsorbent chamber for adsorbing hydrocarbon fuel vapor flowing therethrough; and (2) a second housing containing a membrane, the second housing located adjacent the fresh air line of the evaporative emissions canister for preventing fuel vapor molecules and pollutants associated therewith, from passing through the membrane while allowing the air molecules to pass therethrough. A method is provided for preventing or substantially reducing hydrocarbon emissions to the atmosphere.

Abstract: An evaporative emissions canister for use in an automotive evaporative emission system to control emission of fuel vapors to the atmosphere. The canister includes an integrally molded housing having a circumferential side member, a top member and a bottom member; a hydrocarbon-adsorbing material disposed therein so as to provide a vapor adsorbent chamber for adsorbing hydrocarbon fuel vapor flowing therethrough; and an internal membrane located above the vapor adsorbent chamber in the fresh air side of the adsorbent chamber for preventing the fuel vapor molecules from passing through the internal membrane while allowing the air molecules to pass therethrough. The internal membrane is characterized as a cellular fibular material having physical properties sufficient to effectively cause any fuel vapor component molecules and associated pollutants to be sufficiently filtered or separated on the membrane while allowing fresh air molecules to pass freely therethrough.

Abstract: A receiver trailer hitch carrier is provided, which includes a tray and a receiver tube mounted to the tray. The receiver tube is sized to accept a trailer hitch and is oriented at an acute angle relative to horizontal.

Abstract: A first vehicle power steering system includes a twistable steering torsion bar, a magnet, a Hall sensor, and a valve. The steering torsion bar has a first end fixedly connected to a vehicle steering wheel. The magnet is movable in a first and an opposite second longitudinal direction with respect to the steering torsion bar and is constrained to move in the first longitudinal direction when the steering wheel is turned to the right by a driver and is constrained to move in the second longitudinal direction when the steering wheel is turned to the left by the driver. The Hall sensor has an output and is positioned proximate the magnet. The valve is operatively connected to the output. A second vehicle power steering system includes a twistable steering torsion bar, a ring-magnet support cylinder, a ring-magnet assembly, a ball-and-ramp assembly, a spring, a Hall sensor, and a valve.

Abstract: An endoluminal prosthesis comprises a prosthetic trunk comprising a trunk lumen extending therethrough, a wall, an anastomosis in the wall, and a first fenestration in the wall, wherein the prosthetic trunk has a circumference. The endoluminal prosthesis further comprises a prosthetic branch comprising a branch lumen extending therethrough. The branch lumen is in fluid communication with the trunk lumen through the anastomosis. The prosthetic branch is disposed longitudinally along and circumferentially about the prosthetic trunk.